Medicus Pharma Ltd.
For the period ended Dec 31, 2025. Filed Mar 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 25, 2026
MDCX$1.89+0.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
On November 20, 2025, Ajay Raju, a member of our board of directors, adopted a trading plan intended to satisfy Rule 10b5-1(c) under the Exchange Act to sell, between March 23, 2026, and March 23, 2027, up to 1,000,000 shares of our common shares.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.